Ocular hypertension. Glaucoma suspect: Ocular hypertension
Conditions
Interventions
Intervention 1: First group, will receive oral acetazolamide 250 mg/6h and placebo drops every 8h after capsulotomy with laser for 24 hours. Intervention 2: Second group, will receive Cosopt drops eve
Treatment - Drugs
First group, will receive oral acetazolamide 250 mg/6h and placebo drops every 8h after capsulotomy with laser for 24 hours.
Second group, will receive Cosopt drops every 8h and oral placebo capsule every 6h after capsulotomy with laser for 24 hours.
Sponsors
Arak University of Medical Sciences, Vice chancellor for research
Eligibility
Sex/Gender
All
Age
40 Years to 149 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. age over 40 years; 2. phacoemulsification surgery at least 3 months ago; 3. To have posterior capsule opacity; 4. patient should be operated by phacoemulsification method. Exclusion criteria: 1. asthma and pulmonary obstructive diseases; 2. medication side effects; 3. Retinopathy; 4. severe corneal opacity; 5. occurrence of intraoperative complications; 6. history of glaucoma; 7. Uveitis; 8. absence in the follow up; 9. traumatic cataract.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ocular hypertension. Timepoint: before capsulotomy surgery and 24 hours after capsulotomy surgery. Method of measurement: Goldmann tonometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Ahamad Sarvarian
Arak University of Medical Sciences
Outcome results
None listed